
Monday, August 01, 2022 2:19:54 PM
NEW YORK, July 14, 2022 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH" or the "Company") (CSE: AAWH.U), (OTCQX: AAWH), a leading multi-state, vertically integrated cannabis operator, today announced that it will hold a conference call on Monday, August 15, 2022, at 5:00 PM ET following the release of its second quarter 2022 financial results after market close.
The earnings conference call may be accessed by dialing 1 (888) 390-0605 with conference ID: 06364687. A live audio webcast will also be available on the Investor Relations section of AWH website at https://awholdings.com/investors-overview and will be archived for replay.
Recent AAWH News
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 06/11/2025 08:09:25 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/12/2025 09:22:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2025 08:13:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/02/2025 08:51:24 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/21/2025 08:26:15 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/21/2025 08:24:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/21/2025 08:03:20 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/13/2025 09:12:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/12/2025 08:09:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/14/2025 01:09:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2024 10:16:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/17/2024 10:26:30 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 10:12:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2024 12:28:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2024 09:26:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/05/2024 11:34:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/22/2024 08:21:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/15/2024 11:33:25 AM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM